Genelux Corporation (GNLX) Financials

GNLX Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 26.2 million 10.1 million
March 31, 2026 32.4 million 9.5 million
Dec. 31, 2025 19.0 million 7.5 million
Sept. 30, 2025 25.0 million 6.4 million

GNLX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -8.0 million 2.5 million
March 31, 2026 -7.0 million 1.4 million
Dec. 31, 2025 -6.6 million 810000
Sept. 30, 2025 -7.1 million 2.3 million

GNLX Net Income

No data available :(

GNLX Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 18.7 million - -
March 31, 2026 26.2 million - 2.5 million
Dec. 31, 2025 14.6 million - 1.7 million
Sept. 30, 2025 19.9 million - 1.6 million

GNLX Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 45.0 million
March 31, 2026 32.5 million
Dec. 31, 2025 37.2 million
Sept. 30, 2025 37.9 million

GNLX Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 1.5 million 6.5 million 3.1 million -
March 31, 2026 921000 5.2 million 3.1 million -
Dec. 31, 2025 436000 5.7 million 3.8 million -
Sept. 30, 2025 517000 4.7 million 3.5 million -

GNLX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 - -
March 31, 2026 - 1000
Dec. 31, 2025 8000 148000
Sept. 30, 2025 - -

GNLX

Price: $2.72

52 week price:
2.29
8.54

Earnings Per Share: -0.86 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 121.3 million

Links: